CoChat

Pulmonary Hypertension in Cystic Fibrosis with Advanced Lung Disease

Hayes, Don, Tobias, Joseph D., Mansour, Heidi M., Kirkby, Stephen, McCoy, Karen S., Daniels, Curt J., Whitson, Bryan A. · 2014 · American Journal of Respiratory and Critical Care Medicine

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

Rationale: The impact of pulmonary hypertension (PH) on survival in cystic fibrosis (CF) remains unclear. Objectives: To determine the influence of PH on survival in the CF population. Methods: The United Network for Organ Sharing database was queried from 1987 to 2013 to identify first-time lung transplant candidates who were tracked from wait list entry date until death or censoring to determine influence of PH. Using right heart catheterization measurements, mild PH was defined as mean pulmonary artery pressure greater than or equal to 25 mm Hg and severe greater than or equal to 35 mm Hg. Measurements and Main Results: Of 2,781 CF patients, 2,100 were used for univariate analysis, 764 for Kaplan-Meier survival function, 687 for multivariate Cox models, and 576 and 132 for matching on the propensity of mild PH and severe PH, respectively. Univariate Cox analysis found significant differences in survival for mild PH (hazard ratio [HR], 1.747; 95% confidence interval [CI], 1.387–2.201; P < 0.001) and severe PH (HR, 2.299; 95% CI, 1.639–3.225; P < 0.001). Further assessment by multivariate Cox models identified significant risk for death associated with mild PH (HR, 1.757; 95% CI, 1.367–2.258; P < 0.001) and severe PH (HR, 2.284; 95% CI, 1.596–3.268; P < 0.001). Cox regression stratified on matched pairs of PH cases and control subjects confirmed the risk for death for mild PH (HR, 1.919; 95% CI, 1.290–2.85; P = 0.001) and severe PH (HR, 4.167; 95% CI, 1.709–10.157; P = 0.002). Conclusions: The manifestation of PH is associated with significantly increased risk for death in CF patients with advanced lung disease.

Overview

Integrity signals

Registry

Crossref · 10.1164/rccm.201407-1382oc

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 2

  1. Venuta, 2012, Pulmonary hypertension is associated with higher mortality in cystic fibrosis patients awaiting lung transplantation, J Cardiovasc Surg (Torino), 53, 817
  2. Rovedder, 2008, Prevalence of pulmonary hypertension evaluated by Doppler echocardiography in a population of adolescent and adult patients with cystic fibrosis, J Bras Pneumol, 34, 83

Cited by

See all 77

Metadata

Authors
Hayes, D., Tobias, J. D., Mansour, H. M., Kirkby, S., McCoy, K. S., Daniels, C. J., & Whitson, B. A.
Affiliations
  • Department of Pediatrics
  • The Ohio State University (US)
  • University of Arizona (US)
  • Nationwide Children's Hospital (US)
Corresponding author
Hayes, Don
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2014-10-01
Volume
190
Issue
8
Pages
898-905
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W1984445334
Cited by
77
References
38
Citations by year
2026: 2 · 2025: 3 · 2024: 4 · 2023: 4 · 2022: 3 · 2021: 9 · 2020: 8 · 2019: 9 · 2018: 4 · 2017: 9 · 2016: 7 · 2015: 14
FWCI
8.01
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Respiratory and Critical Care Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
  • Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
Keywords
pulmonary hypertension, cystic fibrosis, advanced lung disease, survival, mortality risk, lung transplant candidates, right heart catheterization, mean pulmonary artery pressure, transplant waiting list
MeSH terms
Adolescent, Adult, Cystic Fibrosis, Female, Humans, Hypertension, Pulmonary, Male, Retrospective Studies, Risk Factors, Severity of Illness Index, United States, Survival Rate, Multivariate Analysis, Proportional Hazards Models, Lung Transplantation, Databases, Factual, Kaplan-Meier Estimate, Young Adult, Propensity Score

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.